Edinburgh Cancer Research

Professor Charlie Gourley named NHS Hero by the Herald

Professor Charlie Gourley’s important contributions to Scotland's healthcare featured by a leading national newspaper: April 2018

Professor Charlie Gourley
Professor Charlie Gourley

This week the Herald is paying tribute to remarkable NHS staff who have made momentous contributions to Scotland's health service during the past 70 years. Professor Charlie Gourley from the Cancer Research UK Edinburgh Centre has been named as one of its NHS Heroes.

Professor Gourley is one of Scotland's leading experts in gynaecological cancers and he was pivotal in pushing for genetic sequencing in ovarian cancer patients after observing in clinical trials that women with BRCA1 and BRCA2 gene mutations responded particularly well to an experimental new drug called Olaparib. He was also the lead investigator in the Edinburgh arm of a global clinical trial for Avastin, a breakthrough ovarian cancer drug shown to starve tumours and prolong survival. Both drugs are now available on the NHS.